Amring Pharmaceuticals https://www.nordicpharmausa.com/ Thu, 14 Mar 2024 14:33:11 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board https://www.nordicpharmausa.com/nordic-group-b-v-through-its-subsidiary-nordic-pharma-inc-u-s-appoints-renowned-oculoplastic-surgeon-john-p-fezza-md-to-its-medical-advisory-board/ Thu, 14 Mar 2024 13:58:19 +0000 https://www.nordicpharmausa.com/?p=1898 March 14, 2024 Nordic Pharma, Inc., a subsidiary of Nordic Group B.V. announced today that eminent oculoplastic surgeon John P. Fezza, MD will serve on its U.S. Medical Advisory Board […]

The post Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board appeared first on Amring Pharmaceuticals.

]]>
March 14, 2024

Nordic Pharma, Inc., a subsidiary of Nordic Group B.V. announced today that eminent oculoplastic surgeon John P. Fezza, MD will serve on its U.S. Medical Advisory Board (MAB).

Read more

The post Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board appeared first on Amring Pharmaceuticals.

]]>
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership https://www.nordicpharmausa.com/amring-pharmaceuticals-inc-announces-name-change-to-nordic-pharma-inc-under-new-nordic-group-b-v-ownership/ Mon, 04 Mar 2024 15:12:43 +0000 https://www.amringusa.com/?p=1891 March 4, 2024 Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in ownership of the company from SEVER Life […]

The post Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership appeared first on Amring Pharmaceuticals.

]]>
March 4, 2024

Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in ownership of the company from SEVER Life Sciences, B.V. to Nordic Group, B.V., a subsidiary of SEVER Life Sciences B.V., which occurred on June 1, 2023.

Read more

The post Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership appeared first on Amring Pharmaceuticals.

]]>
Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair https://www.nordicpharmausa.com/nordic-group-b-v-through-its-subsidiary-amring-pharmaceuticals-inc-appoints-ophthalmology-innovator-eric-d-donnenfeld-md-as-medical-advisory-board-chair/ Mon, 26 Feb 2024 19:11:06 +0000 https://www.amringusa.com/?p=1890 February 26, 2024 Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today that preeminent ophthalmologist Eric D. Donnenfeld, MD will Chair its U.S. Medical Advisory […]

The post Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair appeared first on Amring Pharmaceuticals.

]]>
February 26, 2024

Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today that preeminent ophthalmologist Eric D. Donnenfeld, MD will Chair its U.S. Medical Advisory Board (MAB) which includes Richard Lindstrom, MD (Minnesota), Vance Thompson, MD (South Dakota), Preeya Gupta, MD (North Carolina), Paul Karpecki, OD (Kentucky), Lisa Nijm, MD, JD (Illinois), and Selina McGee, OD (Oklahoma).

Read more

The post Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair appeared first on Amring Pharmaceuticals.

]]>
Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. https://www.nordicpharmausa.com/nordic-group-b-v-through-its-subsidiary-amring-pharmaceuticals-inc-announces-jai-g-parekh-md-mba-as-chief-commercial-officer-eye-care-u-s/ Mon, 15 Jan 2024 17:00:10 +0000 https://www.amringusa.com/?p=1879 January 15, 2024 Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. Read more

The post Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. appeared first on Amring Pharmaceuticals.

]]>
January 15, 2024

Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S.

Read more

The post Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. appeared first on Amring Pharmaceuticals.

]]>
Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical https://www.nordicpharmausa.com/nordic-pharma-group-b-v-through-its-subsidiary-amring-pharmaceuticals-inc-completes-acquisition-of-visant-medical/ Mon, 18 Dec 2023 18:34:09 +0000 https://www.amringusa.com/?p=1859 December 18, 2023 Amring Pharmaceuticals Inc. (Amring),​ a subsidiary of Nordic Group B.V. (Nordic Pharma), ​announced today the completion of its acquisition of Visant Medical, Inc. (Visant), a leader in […]

The post Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical appeared first on Amring Pharmaceuticals.

]]>
December 18, 2023

Amring Pharmaceuticals Inc. (Amring),​ a subsidiary of Nordic Group B.V. (Nordic Pharma), ​announced today the completion of its acquisition of Visant Medical, Inc. (Visant), a leader in medical technology innovation​ in Dry Eye Disease (DED).

Read more

The post Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical appeared first on Amring Pharmaceuticals.

]]>
Amring Pharmaceuticals Inc. issues nationwide Class III recall for 2 lots of Tranexamic Acid Tablets https://www.nordicpharmausa.com/amring-pharmaceuticals-inc-issues-nationwide-class-iii-recall-for-2-lots-of-tranexamic-acid-tablets/ Tue, 13 Jun 2023 20:08:30 +0000 https://www.amringusa.com/?p=1846 June 12, 2023 Read more

The post Amring Pharmaceuticals Inc. issues nationwide Class III recall for 2 lots of Tranexamic Acid Tablets appeared first on Amring Pharmaceuticals.

]]>
June 12, 2023

Read more

The post Amring Pharmaceuticals Inc. issues nationwide Class III recall for 2 lots of Tranexamic Acid Tablets appeared first on Amring Pharmaceuticals.

]]>
Amring Pharmaceuticals Inc. Joins End Drug Shortages Alliance https://www.nordicpharmausa.com/amring-pharmaceuticals-inc-joins-end-drug-shortages-alliance/ Thu, 28 Jul 2022 18:03:05 +0000 https://www.amringusa.com/?p=1715 June 29, 2022 Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today it has joined the End Drug Shortages Alliance (The Alliance), a new coalition of […]

The post Amring Pharmaceuticals Inc. Joins End Drug Shortages Alliance appeared first on Amring Pharmaceuticals.

]]>
June 29, 2022

Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today it has joined the End Drug Shortages Alliance (The Alliance), a new coalition of diverse stakeholders to address drug shortages in the United States. The Alliance provides a forum for key stakeholders to take strategic aim at one of health care’s more pressing and enduring issues, drug shortages that disrupt patient care.

Read more

The post Amring Pharmaceuticals Inc. Joins End Drug Shortages Alliance appeared first on Amring Pharmaceuticals.

]]>
Amring Pharmaceuticals Inc. Announces the Launch of Timolol Maleate Ophthalmic Solution, USP 0.5% https://www.nordicpharmausa.com/amring-pharmaceuticals-inc-announces-the-launch-of-timolol-maleate-ophthalmic-solution-usp-0-5/ Thu, 23 Jun 2022 14:03:15 +0000 https://www.amringusa.com/?p=1708 June 23, 2022 Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Timolol Maleate Ophthalmic Solution, USP 0.5%, […]

The post Amring Pharmaceuticals Inc. Announces the Launch of Timolol Maleate Ophthalmic Solution, USP 0.5% appeared first on Amring Pharmaceuticals.

]]>
June 23, 2022

Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Timolol Maleate Ophthalmic Solution, USP 0.5%, 60 pack of 0.3mL unit dose vials (AT3 rated generic equivalent of Timoptic® in Ocudose®) and has begun commercialization activities.

Read more

The post Amring Pharmaceuticals Inc. Announces the Launch of Timolol Maleate Ophthalmic Solution, USP 0.5% appeared first on Amring Pharmaceuticals.

]]>
Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Lamotrigine Orally Disintegrating Tablets (ODT), USP https://www.nordicpharmausa.com/amring-pharmaceuticals-inc-announces-the-approval-and-launch-of-generic-lamotrigine-orally-disintegrating-tablets-odt-usp/ Mon, 21 Feb 2022 21:39:16 +0000 https://www.amringusa.com/?p=1692 February 14, 2022 Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Lamotrigine ODT, USP (25mg, 50mg, 100mg […]

The post Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Lamotrigine Orally Disintegrating Tablets (ODT), USP appeared first on Amring Pharmaceuticals.

]]>
February 14, 2022

Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Lamotrigine ODT, USP (25mg, 50mg, 100mg and 200mg) available in bottles of 30 tablets (AB rated generic equivalent of Lamictal®), and has begun commercialization activities.

Read more

The post Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Lamotrigine Orally Disintegrating Tablets (ODT), USP appeared first on Amring Pharmaceuticals.

]]>
Amzell B.V. and Amring Pharmaceuticals Inc. Attending 2021 American Epilepsy Society Meeting https://www.nordicpharmausa.com/amzell-b-v-and-amring-pharmaceuticals-inc-attending-2021-american-epilepsy-society-meeting/ Thu, 02 Dec 2021 19:45:14 +0000 https://www.amringusa.com/?p=1659 December 2, 2021 Amzell B.V. (Amzell), a specialist development pharmaceutical company, and Amring Pharmaceuticals Inc. (Amring), a niche generics and value-driven brand company, announced today that they will be in […]

The post Amzell B.V. and Amring Pharmaceuticals Inc. Attending 2021 American Epilepsy Society Meeting appeared first on Amring Pharmaceuticals.

]]>
December 2, 2021

Amzell B.V. (Amzell), a specialist development pharmaceutical company, and Amring Pharmaceuticals Inc. (Amring), a niche generics and value-driven brand company, announced today that they will be in attendance at the 2021 American Epilepsy Society (AES) Annual Meeting in Chicago.

Read more

The post Amzell B.V. and Amring Pharmaceuticals Inc. Attending 2021 American Epilepsy Society Meeting appeared first on Amring Pharmaceuticals.

]]>